Virtual reality training to prevent aggression in psychiatric patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Virtual Reality Aggression Prevention Training (VRAPT) for both forensic and non-forensic psychiatric patients in Switzerland. It aims to address the high prevalence of violent and aggressive behaviors in these populations by implementing a novel virtual reality intervention. The study will assess the feasibility of VRAPT and gather data on its impact on aggressive behaviors among adult and juvenile patients. Previous research has shown some promise for VRAPT in reducing aggression, and this study seeks to expand its application in a new setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* forensic and non-forensic psychiatric in- and out-patients of the Forensic Department or Adult Department of the Psychiatric University Hospitals Basel with aggressive behavior problems according to their clinical treatment team (which includes senior medical doctor, therapist, nursing staff).

Exclusion Criteria:

* insufficient German language skills (in speech or reading);
* intellectual disabilities (IQ \< 70);
* epilepsy;
* acute psychotic state.

Where it's running

• Psychiatric University Hospitals (UPK) Basel
  Basel, Canton of Basel-City, Switzerland Recruiting

Study contacts

• Principal investigator: Cyril Boonmann, PhD — Psychiatric University Hospitals (UPK) Basel
• Study coordinator: Cyril Boonmann, PhD
• Email: cyril.boonmann@upk.ch
• Phone: +41 61 325 82 91

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluation of the redevelopment of Ireland's National Forensic Mental Health Service

  This study is testing how moving to a new 170-bed mental health hospital in Ireland affects the recovery and care of patients with mental health issues involved in the justice system.

  Recruiting Health Service Executive, Ireland · Dublin · NCT05074732

• Predicting bowel leaks after colorectal surgery with a computer model and surgeon input

  This study tests a computer model that predicts anastomotic leaks after colorectal surgery, and sees if adding surgeons’ intuition improves the predictions.

  Recruiting at 2 sites University Hospital, Basel, Switzerland · Liestal, Basel-Landschaft and 1 other locations · NCT07888478

• Active surveillance after immunotherapy for MMR-deficient colorectal and GI cancers

  This study looks at whether some patients with non-metastatic, MMR-deficient or MSI-H colorectal cancers can skip surgery after a strong response to immunotherapy.

  Recruiting at 3 sites University Hospital, Basel, Switzerland · Basel and 2 other locations · NCT07829081

• PCI Registry at University Hospital Basel for Complex Coronary Procedures

  This registry collects real-world data from adults undergoing percutaneous coronary interventions at University Hospital Basel to see how different treatments like drug-eluting stents, drug-coated balloons, and bioresorbable scaffolds perform in diverse patients.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07814157

• Severe Complications During VT/PVC Ablation

  This study looks at real-world cases to see what severe complications occur during VT or PVC ablations and how patients are managed afterward.

  Recruiting at 25 sites University Hospital, Basel, Switzerland · Chicago, Illinois and 24 other locations · NCT07777744

• Visioning III: Five-year follow-up for MRI-based prostate cancer screening

  This study tests a repeat MRI-based screening approach for men who previously had no cancer signs, to see if a negative bpMRI reliably predicts no significant cancer for at least five years.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07762911

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.